About Quadrant Biosciences
Quadrant Biosciences is a company based in Syracuse (United States) founded in 2015. Quadrant Biosciences has raised $14.01 million across 9 funding rounds from investors including NIH and HHS. Quadrant Biosciences operates in a competitive market with competitors including Sunbird Bio, BrainSpec, Courtagen, Mursla and Imeka, among others.
- Headquarter Syracuse, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.01 M (USD)
in 9 rounds
-
Latest Funding Round
$3.5 M (USD), Series B
Aug 08, 2023
-
Investors
NIH
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Quadrant Biosciences
Unlock access to complete
Unlock access to complete
Funding Insights of Quadrant Biosciences
Quadrant Biosciences has successfully raised a total of $14.01M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $3.5 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Quadrant Biosciences
Quadrant Biosciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked |
Investor details for Quadrant Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quadrant Biosciences
Investment portfolio details for Quadrant Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Quadrant Biosciences
Detailed financials for Quadrant Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quadrant Biosciences Comparisons
Peer comparison for Quadrant Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quadrant Biosciences
Quadrant Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sunbird Bio, BrainSpec, Courtagen, Mursla and Imeka, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
|
| Locked | Locked | Locked |
Web-based MRS platform for brain metabolite analysis is utilized.
|
|
| Locked | Locked | Locked |
Provides solutions for neurological and metabolic disorders.
|
|
| Locked | Locked | Locked |
Diagnostic devices for cancer detection are developed using nanostructures.
|
|
| Locked | Locked | Locked |
MRI-based diagnostic software using AI and diffusion imaging is developed.
|
Detailed competitors of Quadrant Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quadrant Biosciences
Complete news archive for Quadrant Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quadrant Biosciences
Quadrant Biosciences was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Quadrant Biosciences is headquartered in Syracuse, United States. It is registered at Syracuse, New York, United States.
Quadrant Biosciences is a funded company, having raised a total of $14.01M across 9 funding rounds to date.
Quadrant Biosciences develops diagnostic products for brain health, creating evolutionary advancements in concussive assessment and autism detection. The company is developing multiple products with different modalities that address ASD and brain concussion. Their brain function tests comprise of a set of tools for the functional assessment of brain health called ClearEdge Brain Health Toolkit and an Autism screening test. The company is also developing a test for the objective detection of concussion by measuring a set of miRNA markers in the patients saliva.
Quadrant Biosciences's top competitors include Sunbird Bio, Mursla and SyntheticMR.